Management of anemia in patients with cancer
β Scribed by David P. Steensma
- Book ID
- 107546296
- Publisher
- Current Science Inc.
- Year
- 2004
- Tongue
- English
- Weight
- 361 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1523-3790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: In 2007, the US Food and Drug Administration (FDA) issued regulatory alerts for use of erythropoiesisβstimulating agents (ESAs) in cancer patients with anemia after clinical trials and metaβanalysis data found that high ESA doses were associated with adverse outcomes in
Supplement based on the proceedings of a satellite symposium at SIOP 2000 in Amsterdam (''Anemia in Pediatric Cancer Patients-How to Manage It?''), and also on the pediatric session of a stand-alone symposium held in Seville, Spain in 2000 (''Evolving Issues in Oncology: What is the 'Optimal' Hemogl